© 1999 by European Society of Cardiology
Copyright © 1999, European Society of Cardiology
Hypertensive left ventricular remodeling and ACE-gene polymorphism
Department of Medicina Sperimentale e Clinica ‘G. Salvatore’, Policlinico Mater Domini, Via T. Campanella 88100, Catanzaro, Italy
* Corresponding author. Tel.: +39-0961-712-264; fax: +39-0961-775-373 perticone{at}unicz.it
Objective:To evaluate the relationship between ACE-gene polymorphism and left ventricular geometry in never treated hypertensives. Methods: We enrolled 200 hypertensive outpatients that underwent clinical and ambulatory blood pressure measurements, echocardiographic evaluation and analysis for insertion (I)/deletion (D) polymorphism by PCR. Patients with normal or increased (>125 g/m2 in males and >110 g/m2 in females) left ventricular mass were considered to have concentric remodeling or concentric left ventricular hypertrophy if their relative wall thickness was 
0.45. Results: The left ventricular mass index values (g/m2) were 136±30 in DD genotype, 124±26 in ID genotype, and 116±20 in II genotype (DD vs. ID P<0.005; DD vs. II P<0.05), and were unrelated to blood pressure. Ninety-six patients presented left ventricular hypertrophy (48.0%): 51 with concentric and 45 with eccentric hypertrophy. The eccentric left ventricular hypertrophy was detected in 32 (36.8%) DD patients, in ten (10.5%) ID patients (P<0.05), and in three (16.6%) II patients. The relative septal thickness was 0.43±0.09 in DD genotype, 0.45±0.08 in ID genotype, and 0.43±0.10 in II genotype. In DD and ID genotypes, the relative posterior wall thickness (0.37±0.07 vs. 0.41±0.07; P<0.0001) and the end-diastolic left ventricular internal dimension (52.8±3.3 mm vs. 48.3±2.8 mm; P<0.0001) were statistically different. Conclusions: The DD genotype of the ACE-gene is associated with an increased left ventricular mass and with a significantly higher prevalence of eccentric left ventricular hypertrophy, when compared to ID genotype.
KEYWORDS ACE-gene polymorphism; Left ventricular hypertrophy; Cardiac remodeling; Hypertension; Cardiovascular risk factors
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Sciacqua, A. Scozzafava, A. Pujia, R. Maio, F. Borrello, F. Andreozzi, M. Vatrano, S. Cassano, M. Perticone, G. Sesti, et al. Interaction between vascular dysfunction and cardiac mass increases the risk of cardiovascular outcomes in essential hypertension Eur. Heart J., May 1, 2005; 26(9): 921 - 927. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. F.C. Schut, G. S. Bleumink, B. H.Ch. Stricker, A. Hofman, J. C.M. Witteman, H. A.P. Pols, J. W. Deckers, J. Deinum, and C. M. van Duijn Angiotensin converting enzyme insertion/deletion polymorphism and the risk of heart failure in hypertensive subjects Eur. Heart J., December 1, 2004; 25(23): 2143 - 2148. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Fernandez-Sola, J. M. Nicolas, J. Oriola, E. Sacanella, R. Estruch, E. Rubin, and A. Urbano-Marquez Angiotensin-Converting Enzyme Gene Polymorphism Is Associated with Vulnerability to Alcoholic Cardiomyopathy Ann Intern Med, September 3, 2002; 137(5_Part_1): 321 - 326. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. M Pinto and W. H van Gilst The ACE gene polymorphism: the good, the bad and the ugly Cardiovasc Res, July 1, 1999; 43(1): 23 - 24. [Full Text] [PDF]
|
|